Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Marc_de_Garidel
|
| gptkbp:country |
gptkb:France
|
| gptkbp:developedBy |
obefazimod
therapies for ulcerative colitis |
| gptkbp:focusesOn |
immunology
inflammatory diseases |
| gptkbp:founded |
2013
|
| gptkbp:founder |
gptkb:Philippe_Pouletty
|
| gptkbp:headquarters_location |
gptkb:Paris
|
| https://www.w3.org/2000/01/rdf-schema#label |
Abivax
|
| gptkbp:industry |
biopharmaceuticals
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:Euronext_Paris
|
| gptkbp:stockSymbol |
gptkb:ABVX
|
| gptkbp:website |
https://www.abivax.com/
|
| gptkbp:bfsParent |
gptkb:Jean-Pierre_Sommadossi
|
| gptkbp:bfsLayer |
7
|